329 results
8-K
EX-99.2
MYGN
Myriad Genetics, Inc.
3 Jun 24
In the Court of Chancery of the State of Delaware
4:06pm
of the Settlement, the Releasing Parties shall waive and relinquish, to the fullest extent permitted by law, the provisions, rights, and benefits of any … that (i) the Corporate Governance Enhancements adopted, implemented, and maintained confer substantial benefits upon Myriad and its stockholders; and (ii
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
3 Jun 24
In the Court of Chancery of the State of Delaware
4:06pm
, and/or maintain the Corporate Governance Enhancements, and that the Corporate Governance Enhancements confer substantial benefits upon Myriad and its
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
7 May 24
Results of Operations and Financial Condition
4:05pm
current liabilities
Unrecognized tax benefits
Long-term debt
Noncurrent operating lease liabilities
Other long-term liabilities
Total liabilities … benefits from any technologies or businesses that it licenses, acquires or develops; the risk that the company is not able to secure additional
8-K
MYGN
Myriad Genetics, Inc.
7 May 24
Results of Operations and Financial Condition
4:05pm
on satisfactory terms, if at all; risks related to the Company’s ability to successfully integrate and derive benefits from any technologies or businesses
ARS
yvekzdjo
17 Apr 24
Annual report to shareholders
4:33pm
8-K
guu5 h4nwwb4v
27 Feb 24
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
pza 6qhmtuvbdegar
27 Feb 24
Results of Operations and Financial Condition
4:05pm
8-K
7nvryt 4w
16 Jan 24
Results of Operations and Financial Condition
9:00am
8-K
EX-99.1
k6esisremjivwhsxibm
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-1.1
eul4 rg2g
13 Nov 23
Entry into a Material Definitive Agreement
4:31pm
424B5
19pfd sgern
13 Nov 23
Prospectus supplement for primary offering
6:02am